Literature DB >> 27613160

'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?

Sean J Udow1,2,3,4, Andrew D Robertson4, Bradley J MacIntosh4, Alberto J Espay5, James B Rowe6,7, Anthony E Lang3,8,9, Mario Masellis1,2,3,4,10.   

Abstract

Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are characterised by abnormal neuroglial α-synuclein accumulation. These α-synucleinopathies have in common parkinsonism and non-motor features including orthostatic hypotension (OH) and cognitive impairment. However, the nature of the relationship between OH and cognitive impairment is unclear. We therefore systematically reviewed the literature for evidence of an association between OH and cognitive impairment in α-synucleinopathies and discuss possible mechanisms and implications of this relationship. Abstracts from 313 original research articles were surveyed, and a total of 132 articles were considered for this review. Articles were stratified as: 'direct-evidence studies' based on the direct assessment for a relationship between OH and cognitive impairment in α-synucleinopathies, and 'indirect-evidence studies' based on an association being referred to as a secondary outcome. Ten 'direct-evidence papers' were identified, seven of which reported a positive association between OH and cognitive impairment, while seven of 12 'indirect-evidence papers' similarly did as well. The papers that reported no association between OH and cognitive impairment used less sensitive measures of cognition. A relationship between OH and cognitive impairment in patients with α-synucleinopathies exists, but the underlying mechanisms remain unclear. Three hypotheses are proposed: (1) OH and cognitive impairment occur concurrently due to diffuse brain and peripheral deposition of α-synuclein, (2) OH-mediated cerebral hypoperfusion impairs cognition and (3) the two act synergistically to accelerate cognitive decline. Longitudinal neuroimaging studies and clinical trials may help clarify the nature of this relationship. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  AUTONOMIC; COGNITION; LEWY BODY; MULTISYSTEM ATROPHY; PARKINSON'S DISEASE

Mesh:

Substances:

Year:  2016        PMID: 27613160     DOI: 10.1136/jnnp-2016-314123

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Orthostatic hypotension acutely impairs executive functions in Parkinson's disease.

Authors:  Michela Sforza; Francesca Assogna; Domiziana Rinaldi; Giuliano Sette; Stefania Tagliente; Francesco E Pontieri
Journal:  Neurol Sci       Date:  2018-04-07       Impact factor: 3.307

2.  Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults.

Authors:  Celia O'Hare; Rose-Anne Kenny; Howard Aizenstein; Robert Boudreau; Anne Newman; Lenore Launer; Suzanne Satterfield; Kristine Yaffe; Caterina Rosano
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Is pure autonomic failure an early marker for Parkinson disease, dementia with Lewy bodies, and multiple system atrophy? And other updates on recent autonomic research.

Authors:  Srikanth Muppidi; Mitchell G Miglis
Journal:  Clin Auton Res       Date:  2017-03-02       Impact factor: 4.435

4.  Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease.

Authors:  Sean J Udow; Maria Eliza Freitas; Susan H Fox; Anthony E Lang
Journal:  CMAJ       Date:  2018-01-15       Impact factor: 8.262

5.  Independent effect of neurogenic orthostatic hypotension on mild cognitive impairment in Parkinson's disease.

Authors:  Sung Hoon Kang; Su Jin Chung; Jungyeun Lee; Seong-Beom Koh
Journal:  Clin Auton Res       Date:  2021-11-29       Impact factor: 4.435

Review 6.  Abnormal circadian blood pressure regulation and cognitive impairment in α-synucleinopathies.

Authors:  Ryota Tanaka; Nobutaka Hattori
Journal:  Hypertens Res       Date:  2022-09-20       Impact factor: 5.528

7.  Cardiovascular autonomic responses in patients with Parkinson disease to pedunculopontine deep brain stimulation.

Authors:  Jonathan A Hyam; Holly A Roy; Yongzhi Huang; Sean Martin; Shouyan Wang; Jodi Rippey; Terry J Coyne; Ian Stewart; Graham Kerr; Peter Silburn; David J Paterson; Tipu Z Aziz; Alexander L Green
Journal:  Clin Auton Res       Date:  2019-09-06       Impact factor: 4.435

8.  Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson's disease.

Authors:  Don Gueu Park; Jae Whan Kim; Young-Sil An; Jaerak Chang; Jung Han Yoon
Journal:  J Neural Transm (Vienna)       Date:  2021-09-27       Impact factor: 3.575

9.  A Single-institution Study on Predictors of Short-term Progression from Mild Cognitive Impairment in Parkinson's Disease to Parkinson's Disease with Dementia.

Authors:  Yuki Tajiri; Kenji Wada-Isoe; Kenichiro Tanaka; Tadashi Adachi; Ritsuko Hanajima; Kenji Nakashima
Journal:  Yonago Acta Med       Date:  2020-01-09       Impact factor: 1.641

10.  Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders.

Authors:  Andrea Pilotto; Alberto Romagnolo; Andrea Scalvini; Mario Masellis; Yasushi Shimo; Laura Bonanni; Richard Camicioli; Lily L Wang; Alok K Dwivedi; Katherine Longardner; Federico Rodriguez-Porcel; Mark DiFrancesco; Joaquin A Vizcarra; Elisa Montanaro; Simona Maule; Alessandro Lupini; Carmen Ojeda-López; Sandra E Black; Stefano Delli Pizzi; Myrlene Gee; Ryota Tanaka; Kazuo Yamashiro; Taku Hatano; Barbara Borroni; Roberto Gasparotti; Maria C Rizzetti; Nobutaka Hattori; Leonardo Lopiano; Irene Litvan; Alberto J Espay; Alessandro Padovani; Aristide Merola
Journal:  Neurology       Date:  2021-06-07       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.